{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_53284"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_53284","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"THE ROLE OF GLUTAMINOLYSIS IN OVARIAN CANCER AND ITS IMPLICATION IN CHEMORESISTANCE","abstract":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Ponton Almodovar, Adriana Lorell"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Horibata, Sachi","Bernard, Jamie J","Neubig, Richard","Jonhson, Brian","Lunt, Sophia"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:44Z","subjects":["Pharmacology"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53284","local:PontonAlmodovar_grad.msu_0128D_22334"],"render_values":[{"text":"etd:53284","href":null,"code":true},{"text":"local:PontonAlmodovar_grad.msu_0128D_22334","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/g33w-p832","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/g33w-p832","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_53284","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Horibata, Sachi","Bernard, Jamie J","Neubig, Richard","Jonhson, Brian","Lunt, Sophia"]},{"key":"dc:creator","label":"Author","values":["Ponton Almodovar, Adriana Lorell"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Pharmacology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53284","local:PontonAlmodovar_grad.msu_0128D_22334","https://doi.org/doi:10.25335/g33w-p832"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2026","Ovarian cancer is recognized as one of the leading causes of cancer-related deaths among females in the United States. Unfortunately, around 75% of patients with this disease eventually develop resistance to platinum-based chemotherapy. Compounded with this, obesity is associated with poorer survival among patients receiving platinum-based drugs. This connection is particularly critical, as obesity is a negative risk factor for ovarian cancer and the omentum is the first site of tumor metastasis. This emphasizes the importance of the non-malignant components within the ovarian tumor microenvironment, which influence progression and contribute to drug resistance. Among these components, cancer-associated adipocytes remain largely unexplored, yet these cells play a pivotal role in influencing tumor behavior. Our research aimed at understanding the metabolic profile of ovarian cancer cells that have developed resistance to platinum-based therapies and to unveil the role of adipocytes in ovarian cancer. We discovered a notable elevation in glutaminolysis and tricarboxylic acid-related metabolites, a metabolic shift that supports enhanced oxidative phosphorylation. This process allows ovarian cancer cells to thrive even under the stress of chemotherapy. Our results show that platinum-resistant cells adopt a glutamine-dependent metabolic state and identify the mitochondrial enzyme glutamic-pyruvic transaminase 2 (GPT2) as the novel driver of these glutamine-driven metabolic alterations. Furthermore, to discern the role of omental adipocytes in ovarian cancer behavior, we developed a novel anchorage-independent 3D model based on human omental fat tissue filtrates. We demonstrated that omental secreted factors enhance ovarian cancer cell proliferation, cell-cycle progression, and migratory morphology. This adipocyte-driven proliferative advantage is intricately linked to GPT2, which functionally links the tumor microenvironment to the metabolic reprogramming observed in platinum-resistant ovarian cancer cells. Ultimately, our research highlights that metabolic reprogramming centered on GPT2 presents a promising therapeutic target for overcoming resistance in platinum-resistant ovarian cancer.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (164 p.) : ill."]},{"key":"dc:title","label":"Title","values":["THE ROLE OF GLUTAMINOLYSIS IN OVARIAN CANCER AND ITS IMPLICATION IN CHEMORESISTANCE"]}]}],"canonical_facts":{"dc:contributor":["Horibata, Sachi","Bernard, Jamie J","Neubig, Richard","Jonhson, Brian","Lunt, Sophia"],"dc:creator":["Ponton Almodovar, Adriana Lorell"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2026","Ovarian cancer is recognized as one of the leading causes of cancer-related deaths among females in the United States. Unfortunately, around 75% of patients with this disease eventually develop resistance to platinum-based chemotherapy. Compounded with this, obesity is associated with poorer survival among patients receiving platinum-based drugs. This connection is particularly critical, as obesity is a negative risk factor for ovarian cancer and the omentum is the first site of tumor metastasis. This emphasizes the importance of the non-malignant components within the ovarian tumor microenvironment, which influence progression and contribute to drug resistance. Among these components, cancer-associated adipocytes remain largely unexplored, yet these cells play a pivotal role in influencing tumor behavior. Our research aimed at understanding the metabolic profile of ovarian cancer cells that have developed resistance to platinum-based therapies and to unveil the role of adipocytes in ovarian cancer. We discovered a notable elevation in glutaminolysis and tricarboxylic acid-related metabolites, a metabolic shift that supports enhanced oxidative phosphorylation. This process allows ovarian cancer cells to thrive even under the stress of chemotherapy. Our results show that platinum-resistant cells adopt a glutamine-dependent metabolic state and identify the mitochondrial enzyme glutamic-pyruvic transaminase 2 (GPT2) as the novel driver of these glutamine-driven metabolic alterations. Furthermore, to discern the role of omental adipocytes in ovarian cancer behavior, we developed a novel anchorage-independent 3D model based on human omental fat tissue filtrates. We demonstrated that omental secreted factors enhance ovarian cancer cell proliferation, cell-cycle progression, and migratory morphology. This adipocyte-driven proliferative advantage is intricately linked to GPT2, which functionally links the tumor microenvironment to the metabolic reprogramming observed in platinum-resistant ovarian cancer cells. Ultimately, our research highlights that metabolic reprogramming centered on GPT2 presents a promising therapeutic target for overcoming resistance in platinum-resistant ovarian cancer.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (164 p.) : ill."],"dc:identifier":["etd:53284","local:PontonAlmodovar_grad.msu_0128D_22334","https://doi.org/doi:10.25335/g33w-p832"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Pharmacology"],"dc:title":["THE ROLE OF GLUTAMINOLYSIS IN OVARIAN CANCER AND ITS IMPLICATION IN CHEMORESISTANCE"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:44Z"}